Sign in
EG

Easterly Government Properties, Inc. (DEA)·Q4 2024 Earnings Summary

Executive Summary

  • Q4 2024 delivered steady GAAP and FFO performance: total revenues rose 7.7% year over year to $78.3M, diluted EPS was $0.05, and Core FFO per share was $0.29; CAD was $25.1M, and EBITDA was $49.9M .
  • Management raised the low end of FY2025 Core FFO guidance to $1.18–$1.21 (from $1.17–$1.21), assuming $100M of wholly owned acquisitions and $25–$75M of development spend; GAAP NI/share guidance moved to $0.20–$0.23 (was $0.24–$0.28) .
  • Portfolio positioning remains defensive: ~95% of leases are firm term, soft-term exposure ~5% of ALI; WALE is 10.0 years and portfolio age 15.7 years as of year-end 2024 .
  • Balance sheet: net debt to TEV increased to 55.2%, adjusted net debt/annualized pro forma EBITDA at 7.1x; weighted-average interest rate 4.6% and maturity 4.5 years .
  • Call tone emphasized “DOGE” (government efficiency) as a structural tailwind for leasing vs. owning; expanding into state/local and “government-adjacent” (e.g., Northrop Grumman) specialized secure facilities is a strategic growth catalyst .

What Went Well and What Went Wrong

  • What Went Well

    • Guidance momentum: raised the low end of FY2025 Core FFO guidance to $1.18–$1.21 on fully diluted basis; reiterated 2–3% annual Core FFO/share growth ambition .
    • Mission-critical moat and long lease terms: ~95% of portfolio leases are firm term, limiting cancellation risk, with soft-term exposure ~5% of ALI; WALE 10.0 years .
    • Strategic expansion into secure “government-adjacent” assets: acquired Northrop Grumman facilities (Aurora, CO; Dayton, OH) and IRS Ogden; management frames leased model as 3x cheaper and faster for labs like FDA vs. government-owned builds. Quote: “we estimate we can deliver a laboratory to the government 3x cheaper and notably faster than it would cost for the government to develop and own it itself.” – CEO .

  • What Went Wrong

    • GAAP earnings outlook: FY2025 NI/share guidance cut to $0.20–$0.23 (from $0.24–$0.28), even as Core FFO low end was raised, highlighting accounting headwinds (e.g., D&A, interest) over non-GAAP cash metrics .
    • Leverage drifted higher: net debt to TEV rose to 55.2% (from 49.0% at Q3), and adjusted net debt/annualized pro forma EBITDA was 7.1x, narrowing balance-sheet flexibility until incremental earnings are realized .
    • Q/Q Core FFO/share dipped: $0.29 in Q4 vs. $0.30 in Q3; real estate taxes and interest expense remain higher year over year (Q4 interest expense $17.2M vs. $13.4M in Q4’23) .

Financial Results

MetricQ2 2024Q3 2024Q4 2024
Total Revenues ($M)$76.221 $74.781 $78.250
Net Income ($M)$4.850 $5.115 $5.729
Net Income per Share – Fully Diluted ($)$0.04 $0.05 $0.05
FFO per Share – Fully Diluted ($)$0.28 $0.28 $0.29
Core FFO per Share – Fully Diluted ($)$0.29 $0.30 $0.29
Cash Available for Distribution (CAD) ($M)$24.806 $25.102 $25.085
EBITDA ($M)$45.889 $46.687 $49.870

Notes: Net income margins calculated from reported figures: Q2 2024 ≈6.4%, Q3 2024 ≈6.8%, Q4 2024 ≈7.3% (derived from Net Income / Total Revenues using figures above) .

Segment/Exposure (as of Dec 31, 2024)

  • Annualized Lease Income by Tenant Type:
    • U.S. Government: $322.842M (93.3%)
    • State & Local Government: $11.361M (3.3%)
    • Private Tenants: $12.122M (3.4%)
  • Top Agency Exposure (ALI %): VA 27.8%, FBI 15.5% .

KPIs and Balance Sheet

KPIQ3 2024Q4 2024
Operating Properties (incl. JV)95 100
Leased Square Feet (approx.)9.3M 9.7M
Weighted Avg Remaining Lease Term10.2 years 10.0 years
Weighted Avg Property Age14.8 years 15.7 years
Net Debt / Total Enterprise Value49.0% 55.2%
Adj. Net Debt / Annualized Pro Forma EBITDA7.0x 7.1x
Weighted Avg Interest Rate / Maturity4.6% / 4.9 yrs 4.6% / 4.5 yrs
Cash & Equivalents ($M)$33.239 (Net Debt table) $20.803 (Exec summary)

Dividend

  • Q4 2024 dividend declared: $0.265 per share, payable March 17, 2025 to holders of record March 5, 2025 .

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Core FFO per Share (fully diluted)FY2025$1.17 – $1.21 $1.18 – $1.21 Raised low end
Net Income per Share (fully diluted)FY2025$0.24 – $0.28 $0.20 – $0.23 Lowered range
Wholly Owned Acquisitions (assumption)FY2025N/A in prior $100M New assumption
Development-Related Investment (assumption)FY2025$25 – $35M $25 – $75M Range widened
Dividend (quarterly)Q3 vs Q4 2024$0.265 (Q3 declared) $0.265 (Q4 declared) Maintained

Earnings Call Themes & Trends

TopicPrevious Mentions (Q2 & Q3)Current Period (Q4 2024)Trend
Government efficiency (DOGE) and lease-vs-ownNot highlighted in Q2 press; Q3 focused on mission-critical resilience and stable growth -CEO emphasized DOGE and GSA shift to leased, modern, secure facilities; cited “3x cheaper” leased lab vs owned Increasing focus, positive tailwind
Portfolio strategy: state/local & “government-adjacent”Q2 acquisitions (ICE Dallas, HSI/ICE Orlando) expanded TAM -Added Northrop Aurora; IRS Ogden; WCPSS campus, continued TAM expansion Broadening beyond federal
Pipeline & spreadsQ3: ~$1.5B pipeline; target 50–100 bps spreads over WACC; WACC low-7s, debt low-6s; targets high-7s/8% cap rates -Reiterated 50–100 bps spread target on next deals Stable
Lease renewals/structureQ3: 2024 key renewals done; expecting mid- to high-teens net effective spreads 95% firm-term leases; soft-term ALI ~5%; renewals ex-TI averaging ~16% spreads (select sample) Solid execution
CAD/dividend coverage roadmapQ3: aim for payout <100% by end-2026 “Within striking distance by end of 2026” reiterated Unchanged
Capex/maintenance cadenceNot highlighted priorRun-rate capex ~$1.75–$2.00 per SF; Q4 seasonality heavier New detail
Macro/political (e.g., Space Force location)Addressed in Q3; underwritten risk stable Emphasis on distributed field offices (FBI) and mission-critical sites Stable/constructive

Management Commentary

  • “We are specialists in delivering mission-critical facilities to key government agencies…The GSA and DOGE have recognized the value in federally leased real estate as a source of cost efficiency for taxpayers.” – CEO .
  • “For the quarter…Net income per share was $0.05 and Core FFO per share…was $0.29…we’re bringing up the bottom end of our core FFO guidance for 2025 to a range of $1.18 to $1.21.” – CFO .
  • “As of quarter end, roughly 5% of the portfolio's annualized lease income is in soft term…The weighted average remaining lease term of the entire portfolio is exactly 10 years.” – CFO .

Q&A Highlights

  • Acquisitions and spreads: Targeting 50–100 bps spread over incremental cost of capital; pipeline remains attractive amid tight bank lending to developers .
  • DOGE/austerity risk: Expect short-term “light chop,” but long-term “smooth landing” as DEA’s specialization supports agency missions; development/lease decision-making favors speed and functionality .
  • CAD trajectory vs. FFO: Management evaluating CAD impact on deals; aiming to have CAD-dividend “within striking distance” by end of 2026 .
  • Capex seasonality: Q4 tends to be heavier; run-rate ~$1.75–$2.00 per SF going forward .
  • Asset recycling: For the FAA/Chicago building, company anticipates a disposition outcome post-expiration .

Estimates Context

  • We attempted to pull S&P Global consensus (Revenue, EPS, and FFO/share) for Q4 2024 and the prior two quarters, but the request was blocked due to an SPGI daily limit. As a result, a quantitative “vs. Street” comparison is unavailable at this time [SPGI request limit error].
  • Implication: Absent consensus, we cannot label beats/misses. Directionally, quarterly Core FFO/share was $0.29 (vs. $0.30 in Q3), and revenues grew year over year, but we cannot benchmark to Wall Street expectations .

Key Takeaways for Investors

  • Defensive cash flows underpinned by mission-critical tenancy and long-dated, predominantly firm-term leases (~95% firm) reduce near-term vacancy/cancellation risk .
  • Strategic TAM expansion (state/local and government-adjacent secure facilities) plus a $100M 2025 acquisition assumption supports 2–3% Core FFO/share growth, with raised FY2025 Core FFO low end to $1.18 .
  • Balance sheet leverage (net debt/TEV 55%) and higher interest expense are watch items; execution on accretive acquisitions and development ramp are key to re-leveraging trends .
  • Near-term catalysts: lease renewal updates (target mid- to high-teens net effective spreads), additional accretive acquisitions at 50–100 bps spreads over capital costs, and progress on FDA Atlanta and Flagstaff courthouse developments .
  • Dividend maintained at $0.265 for Q4 2024; management’s goal is to align CAD/dividend coverage by end-2026, implying progress milestones in 2025–2026 .
  • Policy tailwinds: DOGE/GSA focus on modern leased facilities vs. aging owned stock should benefit DEA’s specialized portfolio and development capabilities over time .